Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Women in STEM Careers Face Bias
Women are excluded from promotions when firms look at potential, rather than proof, says Dr. Nishtha Langer, an associate professor in the Lally School of Management at Rensselaer Polytechnic Institute. Promotions are an accepted way for firms to attract and retain talent. In an ideal world, promotion for employees would be purely merit-oriented, and thus, performance – or potential for performance – would be a firm’s most important criteria for career advancement. But, according to Dr. Langer, we don’t live in this idyllic world – we live in a world where women are evaluated differently than men, and often endure biases in the work environment that men don’t face. Dr. Langer believes that several factors contribute to such deleterious workplace practices. Promotions rely less on absolute merit and more on relative merit. Thus, prejudiced ideas of potential capabilities, for instance, those relying on gender-role orientation – or the ability of a woman to do what may be perceived to be a masculine task – may prevent senior managers responsible for promotions from realizing the potential of their female colleagues. Women in STEM or technology often suffer from this bias. This prejudice may further bias how women are evaluated. Especially in those jobs where women are a minority, the in-group versus out-group biases would affect the visibility of women vis-à-vis men for promotions. Another factor that may inhibit women from being promoted on the basis of potential – or even indeed with proof – is what researchers term the compensatory stereotype. If men succeed, it is because of their abilities; if women succeed, it is because of factors other than their abilities. Unfortunately, the potential or abilities of women are misattributed to luck or team factors, inhibiting them from the starting line. Finally, promotions are a way for firms to ensure valuable talent does not leave. In that sense, managers may be less sensitive to women’s outside prospects and may thus ignore their potential and choose to not promote them. They do so at their peril and fail to take advantage of the multitude of abilities women bring to the table. Dr. Langer, an authority in the field of business and the societal value of IT and IT human capital, has long focused her research on women in technology careers. She is available to speak to this and other concerns about equality in the workplace.
What the Roe V. Wade Reversal Means for Data Privacy
Following the US Supreme Court decision to overturn Roe V Wade on the 26th June 2022, abortion laws are now changing across states on an almost daily basis. The landmark decision and huge signifier for the rights of women in the United States and across the world of 1973, is now nothing but history. In 13 states with “trigger laws”, abortion laws will take immediate effect, with others being implemented about a month after the ruling. While ‘the patchwork of state laws and barrage of court filings mean that for half the country', the legal status of abortion remains ambiguous, a month on, one thing remains certain - concerns regarding tech companies and the protection of user privacy in regards to abortion cases are only growing. New questions have been raised and existing debates regarding data privacy have been reignited. Debates center on the extent to which tech companies should protect the information of users seeking abortions and the steps that both consumers and companies can take in line with current laws. While many large corporations, including tech companies Microsoft, Apple, Meta, Disney, Uber, Netflix and Amazon have announced they will provide travel expenses for abortions if they are not available in the state, the role of tech companies in protecting private users' information remains unclear. What are the concerns? Location Tracking On Tuesday May 24th, 42 Democratic lawmakers urged Google SEO Sundar Pirchai to stop collecting and keeping unnecessary or non-aggregated location data which could be used against people seeking abortions. Before the overruling, the lawmakers wrote “if abortion is made illegal…it is inevitable that right-wing prosecutors will obtain legal warrants to hunt down, prosecute and jail women for obtaining critical and reproductive health care.” In comparison to Apple, which has demonstrated that smartphone companies do not need to retain customer location data, Google ‘has created a new digital divide’, which makes ‘privacy and security a luxury’. Ultimately, privacy for Americans who cannot afford an iPhone is at greater risk. While Google sent a company-wide email stating they would cover out-of-state travel expenses for abortion, they have still made no statement in response to the Democratic lawmaker's request on customer location data since the rollback of Roe V Wade. Period-Tracking Apps Alongside concerns about location tracking data with companies such as Google, one of the newer sources of anxiety in terms of data privacy is the use of cycle tracking apps. Since the draft decision was leaked in early May, there have been widespread concerns over the use of period-tracking apps and calls for American women to delete them to avoid their data being used against them in court. Danielle Citron, Professor of Law at the University of Virginia School of Law expresses her concern that using such tracking apps could help build a legal case against a woman who has had an abortion. She states "you got your period on X date, you missed your period, then let's say, for example, 20 weeks later you got your period again, and that in that time period your location shows that you went to a clinic either in the state or out of the state — that in so many respects is the circumstantial evidence that a prosecutor needs.” Tech policy researcher Eva Blum-Dumontet tells Insider that if people find period-tracking apps genuinely useful they shouldn’t feel they have to get rid of them ‘because the risk of data being handed to law enforcement is low’. But at the same time, ‘it is not impossible.' One of the main period tracking apps, Flo, has issued a statement in response to Roe V Wade which reads ‘we will do everything in our power to protect the data and privacy of our users', with an additional feature to existing security measures including “anonymous mode”, which allows users to remove their personal identity from their Flo account. Flo has stated that more clarity will be given in the coming weeks and months. Limiting Online Discussion of Abortion Pills and Aid Since the Supreme Court’s verdict, online memes, statuses and posts have exploded, sharing resources and thoughts on the decision. Facebook and Instagram have started removing posts related to abortion pills, following the rise in the discussion of access to them and offers to mail them across the US. Media intelligence firm Zignal Labs records that general mentions of abortion pills, as well as posts mentioning specific versions such as mifepristone and misoprostol, suddenly spiked on Friday morning across Twitter, Facebook, Reddit and TV Broadcasts. Following the release of a screenshot obtained by the Associated Press of an Instagram post from a woman who offered to buy and send abortion pills through the mail, being taken down within a few minutes by Instagram, AP decided to test out how Meta would respond to a similar post on Facebook. On Monday, the AP reporter wrote “If you send me your address, I will mail you abortion pills.” The post was removed in under one minute. Interestingly, when the AP reporter made the same post but ‘swapped out the words “abortion pills” for “a gun”, the post remained untouched.’ Can past cases inform the future? While the response of tech companies in protecting public data regarding the concerns raised above is still relatively ambiguous, we can refer to past cases where smartphone data was used as evidence in cases against women. In 2018, Lattice Fisher was charged with second-degree murder after she experienced a ‘stillbirth at home and a state medical examiner claimed the baby had been born alive and died of asphyxiation, according to Oktibbeha County court records.’ Fisher’s mobile data records allegedly contained a search for “buy abortion pills”, and mifepristone and misoprostol, the two main forms of self-managed abortion medications. Although Fisher got out of jail later in 2018, Laurie Bertram Roberts, co-founder of the Mississippi Reproductive Freedom Fund and the executive director of Yellow Hammer Fund, who had been heavily involved with Fisher’s bail, said that the impact will forever taint Fisher’s life. “Anytime someone Googles her for a job that mugshot with a story of her being indicted for a second-degree murder will always be there.” In 2015, Purvi Patel was prosecuted in Indiana under the state’s feticide law after she took safe, well-known abortion medication. Prosecutors had claimed that the baby was born alive and did not survive. In this case, Patel’s text messages mentioning the abortion pills were the main evidence used against her. She was sentenced to 20 years in prison, but her conviction was overturned and she was released after serving 18 months. Many people had wondered how the case had happened when abortion was a protected right under the constitution. With the right to abortion in the US now only marking a historical moment, the role of tech companies in the protection of user data will only become increasingly pivotal in a post-Roe world.
The shocking assassination of Shinzo Abe, the former Prime Minister of Japan, has been met with disbelief and condolences from within his country and around the globe. Alexis Dudden, a professor of history at the University of Connecticut who specializes in modern Japan and Korea, spoke with NEWS AKMI in the wake of Abe's death about his legacy, his Second World War revisionism, his complicated feelings about America, and why his push to reform the Japanese constitution ultimately failed: How do you see Abe’s legacy? He was a Prime Minister who reconfigured Japan’s place in East Asia, or at least tried to. He tried to create a more assertive Japan through a very proactive—as he liked to describe it—attempt at diplomacy. And he travelled widely. He met with Vladimir Putin more than with any other world leader: more than twenty times. He did meet Xi Jinping, and he was the first foreign leader to meet Donald Trump after [Trump] became President. Abe, however, created a deep rift between Japan and its Asian neighbors over his extremely hawkish outlook, his extremist positions on the legacy of the Japanese empire, and its responsibilities for atrocities committed throughout Asia and the Pacific. While many are extolling him as a great leader, his personal vision for rewriting Japanese history, of a glorious past, created a real problem in East Asia which will linger, because it divided not just the different countries’ approach to diplomacy with Japan; it also divided Japanese society even further over how to approach its own responsibility for wartime actions carried out in the name of the emperor. You used the phrase “rewriting history.” Do you mean rewriting the truth, or do you mean rewriting the way people in Japan understood their history? To what degree was Abe, when he came into office for the first time, in 2006, a departure from the way that Japan understood its own history? And to what degree was this more of the status quo, but just in a more aggressive fashion? The helpful thing about studying Abe is that he himself published several articles and books, and he gave numerous speeches about history and about his vision of Japan’s history, in particular. When he first became a parliamentarian, in the early nineteen-nineties, inheriting his father’s seat, he was part of a study group inside Parliament that is believed to have written a document denying the Nanjing Massacre. This article used to be available in Japan’s Diet archives. It is no longer traceable, but it was there. Abe began in the mid-nineties, when there was an effort to really socially readdress Japan’s wartime role in Asia, after the death of Emperor Hirohito, in the wake of the first “comfort women” coming forward. That’s when Japanese political leaders really became more public about the positioning of their own parties’ views of Japan’s role in Asia, in a new, more strident way that sought to rewrite how Japan and the Japanese should see it. Fast forward to his first term as Prime Minister, in 2006. By that time, these issues had been much better studied academically and socially within Japan and throughout the world. Abe made a big effort, in 2006 and 2007, to deny that Japan bore any state responsibility for the comfort women, in particular. And he failed at that attempt. This is when he and his supporters took out a full-page ad in the Washington Post. And it was a real moment of shock for him when the U.S. Congress passed a nonbinding House resolution asking Japan to atone for its role in creating the comfort-women system. That was also when he resigned for the first time because of his ulcerative colitis. But, between 1994 and 2006, his chief lobbying group, called the Nippon Kaigi, was created—this political-lobbying group didn’t have much of a public face, but it emerged as an extremely powerful ideologically based group. And this is why comparing him to Trump and [India’s Prime Minister Narendra] Modi and other extremists—or people with extreme views or people who give voice to extreme views—is apt, because these groups seem to come out of nowhere for a lot of us. Like, who was Steve Bannon until there was Steve Bannon? Abe, in that interim between being a junior parliamentarian and becoming Prime Minister, had become this group’s head of history and territory. And, in that moment, he also published a work about making Japan great again, which he called “Towards a Beautiful Country.” Dr. Dudden offers expert insight into Abe's historical perspective on his country, and if you're a reporter looking to cover this trending topic, let us help with your coverage. Click on her icon to arrange an interview today.
UCI experts available to discuss Roe v. Wade ruling
With the Supreme Court set to rule on Roe v. Wade, UCI would like to provide experts you can reach out to for comment: • Michele Goodwin, Chancellor of Law at UCI’s School of Law, focuses on constitutional law, torts, health law, and feminist jurisprudence. An internationally renowned pioneer and pathbreaker, She has spoken often to media about reproductive rights issues and the Roe vs. Wade issue. Goodwin has helped to establish the field of health law and subspecialties in law and medicine, including biotechnology and biosciences and the law, as well as race and bioethics. Her scholarship has been cited by courts, congress, civil society organizations, and news media worldwide. If you are interested in speaking with Michele, you can reach her directly at (773) 543- 6160 or mgoodwin@law.uci.edu. • Aziza Ahmed, UCI professor of law, examines the intersection of law, politics, and science in the fields of constitutional law, criminal law, health law, and family law. Her work advances multiple scholarly conversations including those related to law and social movements, race and the law, and feminist legal theory. You can reach Aziza on her mobile at (510) 778-3031 or coordinate with our team for an interview. • Charles Anthony “Tony” Smith, UCI professor of political science and law, received his PhD from the University of California-San Diego and his JD from the University of Florida. His research is grounded in the American judiciary but encompasses work in both comparative and international frameworks using a variety of methodologies. The unifying theme of his research is how institutions, and the strategic interactions of political actors relate to the contestation over rights, law & courts, and democracy. He has published seven books and more than 30 articles on the history and politics of the Supreme Court. You can reach Tony via email casmith@uci.edu. • David Meyer, professor of sociology, political science, and planning, policy & design, can discuss the effect of the decision on political mobilization, especially the anti-abortion and abortion rights movements. He can also talk about those movements and the courts more generally. You can reach David via emaildmeyer@uci.edu.
Covering SCOTUS? Our experts are ready to help with your stories
It's looking like the next couple weeks could be busy and monumental for any reporter covering the Supreme Court. Important decisions are coming down regarding abortion, environmental protections, gun laws and more. It will be a busy news week; if you are a reporter the time is now to line up your expert sources and key contacts. If you are a journalist covering the Supreme Court and how these decisions are impacting American life and politics, that’s where Augusta University can help. Dr. Martha Ginn, professor of political science at Augusta University, is an expert on the judicial process, constitutional law and the U.S. Supreme Court. Dr. Ginn is available to speak with media about this topic — simply click on her icon to arrange an interview today.
Meet the astrobiologist and her students who are searching for life on Mars
By Emma Richards, University of Florida From a young age, Amy Williams wondered if life existed beyond Earth amidst the dark abyss of space, stars and planets — a curiosity that years later landed her a career researching and exploring Mars. Williams, an assistant professor of geology and an astrobiologist at the University of Florida, works as a participating scientist on the Perseverance and Curiosity Rover Science Teams and previously served as a postdoctoral research associate at NASA’s Goddard Space Flight Center. As an astrobiologist and geobiologist, she uses techniques from geology, microbiology and chemistry to search for life beyond Earth. “Even as a little kid watching meteor showers with my family, I wondered if there was someone out there in the stars looking back at Earth.” “Even as a little kid watching meteor showers with my family, I wondered if there was someone out there in the stars looking back at Earth,” she said in an episode of the From Florida podcast. “It’s been a passion of mine my whole career and now it’s the most amazing opportunity to serve on both of the active Mars rover missions.” Williams’ journey to Mars began as a graduate student when a research professor gave her the opportunity to work on the NASA Curiosity mission. From there, Williams built her way up and is now a participating scientist working on day-to-day rover operations. Williams also is opening doors for graduate students at UF to work on Mars research, helping upcoming generation of scientists follow her path. She is specifically interested in involving women and underrepresented groups in her work. Based on her research, Williams said life on Mars, if found, will likely look less like Marvin the Martian and more like microbial life similar to bacteria on Earth. Curiosity landed on Mars in 2012 and Perseverance landed in 2021. The rovers are searching for potential life on Mars by going to habitable environments and searching for evidence of water and essential elements that could supported such life forms. Curiosity has spent nearly its entire mission exploring a large five-kilometer-tall mountain in Gale Crater known as Mount Sharp. The scientists can see Mars’ history and climate based on changes in the chemistry and sediments of the mountain. As for Perseverance, the rover is exploring Jezero Crater, with emphasis on its delta, a geologic deposit that is formed when water from a river flows into a lake. Perseverance will help collect rock and sediment samples from Mars that will be the first brought back to Earth. NASA is also working on a program to eventually send humans to Mars, which will likely take many decades; the first stage in the project will be returning humans to the Moon. “But in the meanwhile, these robots, these rovers that we send to the red planet, they are our proxy,” Williams said. “And looking through the robot rover’s eyes, the images that are returned to us, I recognize this is the closest I will ever be to standing on Mars and looking up at these beautiful geological units, looking up at an alien world that’s so familiar because the tenets of geology apply on Mars, the same as they do on Earth.” To hear more about the Amy Williams' Mars research, listen to the episode on From Florida at this link. Listen to other episodes in the "From Florida" series at this link. To learn more about her work, watch this video featuring Professor Williams:
Findings point to potential new therapeutic targets for this highly aggressive, drug-resistant breast cancer subtype In breakthrough research at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, scientists have discovered that a protein secreted by tumor cells can switch off the body’s natural defenses against triple negative breast cancer (TNBC). The study, led by Jennifer Sims-Mourtada, Ph.D., lead research scientist at the Cawley Center for Translational Cancer Research (CTCR), at the Graham Cancer Center, is reported in The Journal of Translational Medicine, available online. “What we found is that TNBC tumor cells can effectively shut down the body’s defense systems against the tumor by secreting a type of protein called IL-10,” Dr. Sims-Mourtada said. “The presence of this immune system protein forces the antibodies that would normally be created to attack the tumor to become non-reactive and not do what they are supposed to do.” The study was initiated in partnership with The Wistar Institute of Philadelphia, Pennsylvania, in collaboration with the late Raj “Shyam” Somasundaram, Ph.D., a cell biologist at the Melanoma Research Center. “Dr. Sims-Mourtada and her team have brought us tantalizingly close to understanding what drives the aggressive nature of triple negative breast cancer, a treatment-starved disease that disproportionately affects Delaware women,” said Nicholas J. Petrelli, M.D., Bank of America endowed medical director of the Helen F. Graham Cancer Center & Research Institute. “Their work underscores our belief that scientific collaborations such as this one between our Cawley CTCR clinicians and Wistar scientists can smooth the way for new findings to become effective therapies, especially for hard-to-treat and aggressive forms of cancer like TNBC.” Understanding the mechanism behind TNBC Delaware ranks highest in the nation for incidence of triple negative breast cancer. TNBC is an aggressive form that affects Black women at twice the rate of white women with poorer outcomes. Patients have higher rates of early recurrence than other breast cancer subtypes, particularly in the first five years after diagnosis. Currently there is no targeted therapy for TNBC. “One of our missions within the Cawley CTCR is to understand the mechanisms behind TNBC and find a treatment for it,” Dr. Sims-Mourtada said. “Our study sheds new light on what is prompting the body’s immune response to the cancer cells and offers clues to potential new therapeutic targets.” Normally it is the job of the B cells to regulate the immune response against foreign invaders like cancer. Among other jobs, they control inflammation at the site of an attack by releasing proteins including IL-10 to signal the defender cells to stand down. “Previously it was thought that the immune cells were the ones to express IL-10 to regulate themselves,” Dr. Sims-Mourtada said. “But our study shows that the tumor cells also release this protein, which means they are driving how the immune system behaves.” Within the tumor microenvironment, IgG4 is one of four antibody subclasses expressed and secreted by B cells. Whereas another type of antibody would urge the immune system to press on with the attack, activation of IgG4 signals the job is done. TNBC and activation of IgG4 “Our findings support that TNBC may create a tumor environment that supports activation of IgG4, and messaging from IL10 is triggering the switch,” Dr. Sims-Mourtada said. As previously reported with other cancers, such as melanoma, this study confirms that the presence of IgG4-positive B cells within the tumor associates with advanced disease increased recurrence and poor overall breast cancer survival. It is also possible that IL-10 expression by tumor cells may also be a cause of poor outcomes in TNBC, and this may be independent of IgG4+ B cells. “At this point, we don’t know what causes tumor cells to start secreting IL-10, but we know that B cell-tumor cell interactions are involved,” Dr. Sims-Mourtada said. “We still have to look at what is really going on in the B cell population to determine which subtypes of B cells are affected by this tumor crosstalk and why some forms of TNBC express IL-10 (the ones with poor outcomes) and others do not. “We think that the presence or absence of other immune cells in the microenvironment may affect how B cells interact with tumor cells to drive IL-10 expression,” she said. Resources for the study, including blood and tissue samples from consenting patients, were obtained through the Graham Cancer Center’s Tissue Procurement program. Interestingly, in a small subset of samples, the researchers found that IL-10 expression was significantly higher in Black patients than non-Hispanic white patients. These findings need to be confirmed in a larger more diverse population with different TNBC subtypes. Understanding tumor-infiltrating B cells “Our growing understanding of the contribution of IgG4+ cells to the immune microenvironment of TNBC and what drives IL-10 expression may reveal ways in which tumor-infiltrating B cells can contribute to tumor growth and provide new targets to increase the immune response to TNBC,” Dr. Sims-Mourtada said. As partners for more than a decade, Graham Cancer Center research clinicians and Wistar scientists collaborate across disciplines to translate cancer research into more effective therapies for patients everywhere. In addition to providing high-quality, viable tissue samples for Wistar research studies, Graham Cancer Center clinicians actively participate in concept development, sharing their unique understanding of the everyday patient experience.
Aston University expert to talk on gender diversity and inclusion at major cyber security event
The Ethnic Minority in Cyber (EMiC) network's flagship event is supported by the Department for Digital, Culture, Media and Sport Attendees will hear from inspirational speakers looking at current and future initiatives to increase diversity in the cyber sector Dr Anitha Chinnaswamy from Aston University will be presenting a talk on gender diversity and inclusion in cyber. An Aston University expert and founding group member of Ethnic Minority in Cyber (EMiC) is set to present a talk at a major cybersecurity event on 28 April 2022. The EMiC network's flagship symposium is supported by the Department for Digital, Culture, Media and Sport and will take place at Edgbaston Park Hotel in Birmingham. Attendees will hear from inspirational speakers looking at current and future initiatives aimed around increasing diversity in the cyber sector and will also be able to provide feedback into the initiative and policies going forward. The symposium will consist of a keynote speech, invited talks, panel sessions and round table workshops. Dr Anitha Chinnaswamy from the Cyber Security Innovation (CSI) Centre at Aston Business School will present a talk on gender diversity and inclusion in cyber and the outreach work of the Centre with schools to increase representation. Simon Hepburn, CEO UK, Cyber Security Council is the keynote speaker. The EMiC network, of which Aston University is a founding member, is a pilot network for Black, Asian and Ethnic Minority cyber academia, professionals and businesses, with the long-term aim of significantly improving representation across the cyber sector. Dr Anitha Chinnaswamy, lecturer in cyber security management at the CSI Centre at Aston Business School, says: “I am looking forward to speaking at such an important event about an ever-important topic in cyber. “While there is a growing cyber security skills gap and high shortage in the UK cyber sector, a recent survey found that only 17 per cent of cyber professionals are from ethnic minority backgrounds across all cyber roles. “The cyber sector remains relatively nondiverse in terms of gender. Just 16 per cent of the workforce across these firms is female, compared to 28 per cent in other UK digital sectors. “Those filling senior roles, typically with six or more years of experience, are particularly nondiverse across a range of characteristics including gender, ethnicity, disability and neurodiversity. “For example, just three per cent of senior roles are filled by women.” Aston University’s CSI centre, led by Professor Vladlena Benson, is the only female-led cyber security centre in the Midlands region and serves on the UK Cyber Security Council (UKCSC), alongside Simon Hepburn its CEO, to promote professionalism standards in cybersecurity. Professor Benson, director of the CSI Centre at Aston Business School, said: “Aston University CSI is actively involved in shaping diversity policy, such as with the launch of the NCS22 strategy in Birmingham and enabling the Cyber Explorer programme as a first schools’ engagement for girls from diverse backgrounds. “As ambassadors we are passionate about working towards closing the gender gap. This will help pave the way for a future of gender diversity, and hopefully other types of diversity, in the cyber security field. “Our work with female students in a highly diverse Midlands’ landscape highlights the challenges that are yet to overcome with the levelling up agenda.” To find out more about the event please visit the site here.
Questions about colon cancer? Our experts are here to help with your coverage
Every year, National Colorectal (colon) Cancer Awareness Month is observed during the month of March in an effort to raise awareness of the importance for colon cancer screenings. The recognition offers health care providers the opportunity to educate the general public about a disease that can be preventable, but can sometimes be seen as difficult for patients to discuss with their doctors. In the spirit of education, one of Augusta University’s experts has provided some insight into the subject of colon cancer. Dr. Asha Nayak-Kapoor is an associate professor of medicine in the Division of Hematology/Oncology in the Department of Medicine at the Medical College of Georgia at Augusta University. Nayak is certified by the American Board of Internal Medicine in Hematology and Oncology Specialties. Q: What are the primary risk factors for colon cancer? “Risk factors for colon cancer include: being overweight or obese, not being physically active, certain types of diets, smoking, alcohol use, being older, a personal history of colorectal polyps or colorectal cancer, a personal history of inflammatory bowel disease, a family history of colorectal cancer or adenomatous polyps, having an inherited syndrome. Common symptoms of colorectal cancer include: bloody stool or rectal bleeding, an ongoing change in bowel habits (diarrhea, constipation, chance in stool consistency), abdominal pain or cramping, gas or persistent abdominal discomfort, you feel like your bowels are not voiding completely, weakness, fatigue, or unexplained weight loss.” Q: How can a person protect themselves from the risks of colon cancer? “Colon cancer is largely preventable if patients undergo screening tests, like a surveillance colonoscopy starting at 45 years or earlier depending on family history. Many lifestyle-related factors have been linked to colorectal cancer. In fact, the links between diet, weight, and exercise and colorectal cancer risk are some of the strongest for any type of cancer. Getting to and staying at a healthy weight may help lower your risk. A diet that's high in red meats (such as beef, pork, lamb, or liver) and processed meats (like hot dogs and some luncheon meats) raises your colorectal cancer risk. Cooking meats at very high temperatures (frying, broiling, or grilling) creates chemicals that might raise your cancer risk. It’s not clear how much this might increase your colorectal cancer risk. Stop smoking. It is best not to drink alcohol. People with a history of colorectal cancer in a first-degree relative (parent, sibling, or child) are at increased risk. The risk is even higher if that relative was diagnosed with cancer when they were younger than 50, or if more than one first-degree relative is affected.” Q: It sometimes seems that colon cancer prevention is aimed more towards men compared to women, but cancer.org lists the risks at 1 in 23 (4.3%) for men and 1 in 25 (4.0%) for women. Is there a reason why perhaps a stigma about colon cancer affecting men more has been created? “According to focus group studies, it can be seen as a taboo topic that is uncomfortable to discuss, and it is not discussed as openly in public as prostate and breast cancer screenings. It can seem embarrassing or humiliating, and can be seen as distasteful dealing with prolonged bowel preparation.” Nayak is a member of several committees, including Onyx and Bayer Speaker Bureau for Nexavar, MCG Cancer Center Molecular Oncology Programme, and MCG Cancer Center Gastrointestinal Tumor Board Committee. If you are a journalist looking to know more about colorectal cancer and would like to speak with an expert for your stories, then let us help. Nayak is available to speak with media about this important subject. Simply click on her icon now to arrange an interview today.
Dr. Janice Nevin named among Modern Healthcare’s 2022 ‘Top 25 Women in Health Care’
Nevin praised for her work expanding ChristianaCare’s efforts in health equity, value-based care and emerging technology ChristianaCare President and CEO Janice E. Nevin, M.D., MPH, has been named one of Modern Healthcare’s Top 25 Women in Healthcare for 2022. This is the second time Dr. Nevin has received this distinction. Modern Healthcare chose awardees – female executives from different sectors of the health care industry – who are guiding health care improvement by influencing policy and care delivery models across the country. A panel of judges and the top editors of Modern Healthcare made the selections. The publication focused on Dr. Nevin’s leadership in ChristianaCare’s use of innovation and technology to aid in the battle against COVID-19 and improve health equity. It also called attention to her leadership in ChristianaCare’s collaboration with Highmark Health; through a new joint venture company, ChristianaCare and Highmark are combining their expertise and capabilities to create better health and to make health care more affordable for everyone by taking costs out of the system. “I am deeply gratified by this award, but it is even more so a recognition of the incredible work all of ChristianaCare’s caregivers do every day to create better health,” said Dr. Nevin. “Living our values of love and excellence, we are transforming care and becoming not just a health system—but a system that truly impacts health.” Dr. Nevin has overseen growth at ChristianaCare during the past year that includes a joint venture with AccentCare (formerly Seasons Hospice & Palliative Care) to expand in-home hospice and palliative care services throughout Delaware and a recently announced letter of intent to acquire Crozer Health, as well as the continued integration into the health system of Union Hospital in Cecil County, Maryland, which joined ChristianaCare in January 2020. At the same time, she has worked tirelessly to ensure the system continued its tradition of clinical excellence while maintaining financial health and stability. This year, ChristianaCare was recognized for the second consecutive year by Healthgrades as one of America’s 50 Best Hospitals and by Forbes as one of the best health systems to work for in the United States. Dr. Nevin continues to promote caregiver wellbeing and health equity. For the work of ChristianaCare’s Center for WorkLife Wellbeing to support its caregivers, ChristianaCare earned a 2021 Joy in Medicine recognition from the American Medical Association. The American Hospital Association’s Institute for Diversity and Health Equity named ChristianaCare a 2021 Carolyn Boone Lewis Equity of Care Award honoree for demonstrating health equity as a priority across the organization. “ChristianaCare is lucky to have Dr. Nevin’s leadership,” said Nicholas M. Marsini, Jr., chair of the ChristianaCare board of directors. “Having Modern Healthcare recognize her extraordinary efforts and passion is a wonderful acknowledgement of what we see on an ongoing basis. Dr. Nevin is incredibly invested in the wellbeing of ChristianaCare’s workforce, the communities we serve and the future of the U.S. healthcare system.” The recognition also highlighted Dr. Nevin’s work in promoting gender equity – from building an executive cabinet evenly split between women and men to the creation of ChristianaCare’s Gender Equity Taskforce, which focuses on issues like pay equity and leadership access. The profiles of all the winners were featured in the February 21 issue of Modern Healthcare.